Related Experiment Video
Updated: Jun 10, 2026
12:04
The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
Published on: November 1, 2015
Cutaneous lupus erythematosus: recent lessons from animal models
1Department of Dermatology and Skin Science and Child and Family Research Institute, University of British Columbia, Canada.
Lupus
|August 10, 2010
Summary
Animal models reveal key immune pathways in cutaneous lupus erythematosus (CLE). Understanding interleukin-6, -18, and -21, plus other factors, aids in developing targeted therapies for this skin condition.
Area of Science:
- Immunology
- Dermatology
- Animal Models
Background:
- Cutaneous lupus erythematosus (CLE) presents diverse skin lesions with shared histopathology.
- Understanding CLE immunopathology is crucial for effective therapeutic targeting.
Purpose of the Study:
- To review animal models elucidating immune alterations in CLE.
- To identify potential therapeutic targets based on animal studies.
Main Methods:
- Review of existing literature on animal models of CLE.
- Analysis of studies involving MRL/lpr mice and gene-manipulated strains.
- Examination of the roles of specific cytokines and growth factors.
Main Results:
- MRL/lpr mice exhibit spontaneous skin disease resembling CLE.
- Cytokines such as interleukin (IL)-6, IL-18, and IL-21 are implicated in CLE pathogenesis.
- Colony stimulating factor 1 and high-mobility group box 1 may also play a role.
Conclusions:
- Animal models provide valuable insights into CLE immune mechanisms.
- Identifying key cytokines and factors offers potential for novel treatment strategies in CLE.
